Lord, Abbett & Co. LLC Spring Works Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 1,069,738 shares of SWTX stock, worth $44.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,069,738

Previous 2,073,970 48.42%

Holding current value

$44.8 Million

Previous $78.1 Million 56.13%

% of portfolio

0.11%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $32.2 Million - $42.9 Million	-1,004,232 Reduced 48.42%	1,069,738 $34.3 Million
Q2 2024 Oct 07, 2024	SELL	$36.06 - $47.62 $8.79 Million - $11.6 Million	-243,840 Reduced 10.52%	2,073,970 $78.1 Million
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $8.79 Million - $11.6 Million	-243,840 Reduced 10.52%	2,073,970 $78.1 Million
Q1 2024 Oct 07, 2024	BUY	$36.5 - $52.5 $8.9 Million - $12.8 Million	243,840 Added 11.76%	2,317,810 $114 Million
Q1 2024 May 09, 2024	BUY	$36.5 - $52.5 $84.6 Million - $122 Million	2,317,810 New	2,317,810 $114 Million
Q2 2022 Aug 12, 2022	SELL	$18.36 - $60.07 $3.78 Million - $12.4 Million	-206,054 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$48.97 - $65.46 $8.47 Million - $11.3 Million	-172,953 Reduced 45.63%	206,054 $11.6 Million
Q4 2021 Feb 11, 2022	BUY	$53.3 - $75.84 $1.34 Million - $1.9 Million	25,091 Added 7.09%	379,007 $23.5 Million
Q3 2021 Nov 09, 2021	BUY	$62.66 - $88.26 $19.3 Million - $27.2 Million	308,468 Added 678.73%	353,916 $22.5 Million
Q2 2021 Aug 11, 2021	BUY	$67.45 - $85.63 $3.07 Million - $3.89 Million	45,448 New	45,448 $3.75 Million
Q1 2021 May 11, 2021	SELL	$65.1 - $93.59 $2.74 Million - $3.93 Million	-42,032 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$48.36 - $77.92 $2.03 Million - $3.28 Million	42,032 New	42,032 $3.05 Million

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.61B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Spring Works Therapeutics, Inc. Transaction History